SKILLMAN, N.J., Aug. 24, 2012 /PRNewswire/ -- ConvaTec today announced that it will report its 2012 second quarter earnings on Wednesday, August 29, 2012. Ken Berger, CEO and Ed Borkowski, CFO will host an analyst and investor call at 9:00 AM ET live via telephone.
To participate in the conference call within the U.S. and Canada, dial (866) 524-0629.
To participate in the conference internationally, dial (708) 290-1340.
The conference ID is 23133321
Participants should dial in 10 minutes prior to the start of the call. The Company’s unaudited, 2012 Second Quarter Report will be filed on the Company’s website prior to the call under the Investor Community tab at www.convateccorporate.com.
For more information, please contact investorrelations@convatec.com
About ConvaTec
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.
Investor Relations: | Media Relations: |
Tim Winston | Amy Firsching |
VP, Treasurer | Associate Director, Corporate Communications |
ConvaTec | ConvaTec |
908-904-2088 | 908-904-2988 |
SOURCE ConvaTec
